Tools

Explore

Videos Channels Figures

Atmrix

Tools

Explore

Videos Channels Figures

Atmrix

DT

Derek Thompson

04/04/25

@ Y Combinator

Advanced Market Commitments can accelerate technological development by promising financial rewards for successful innovations, as demonstrated during the rapid vaccine development process.

Video

How To Build A Truly Abundant Future

@ Y Combinator

How To Build A Truly Abundant Future

04/04/25

Related Takeaways

Patrick Collison

02/22/24

@ Dwarkesh Patel

Many vaccines that could exist, like for Lyme disease, do not due to market failures and safety concerns, indicating a need for advanced market commitments to stimulate development in these areas.

Elizabeth Iorns

10/03/18

@ Y Combinator

Biotech MVPs are challenging to define because commercial revenue typically only comes after product approval, which many biotechs never achieve.

Elizabeth Iorns

10/03/18

@ Y Combinator

Recent approvals of gene therapies and cell-based therapies have opened new avenues for biotech companies to create marketable products.

Winston Weinberg

03/11/25

@ Sequoia Capital

I emphasize the importance of moving quickly to avoid missing significant opportunities in the market, as the pace of innovation is accelerating.

Y Combinator Cast

01/25/25

@ Y Combinator

Big companies struggle to adapt quickly to new technologies, giving startups an advantage in securing enterprise contracts by being agile and innovative.

Derek Thompson

04/04/25

@ Y Combinator

The concept of 'push funding' involves providing upfront financial support to companies, while 'pull funding' guarantees rewards for achieving specific technological milestones, encouraging innovation.

Elizabeth Iorns

10/03/18

@ Y Combinator

Access to capital and FDA's development strategies for rare diseases have enabled small biotech companies to bring products to market without being acquired.

Y Combinator Cast

05/30/25

@ Y Combinator

The forward deployed engineer model allows startups to close significant deals with large enterprises by demonstrating innovative solutions that meet customer needs.

Elizabeth Iorns

09/14/17

@ Y Combinator

Biotech companies often use their time in Y Combinator to conduct critical path experiments and work with external companies for proof of concept studies, which can advance their regulatory filing status.